Page Views
Site
MS1Page
https://gsk-vaccines.infinityloop.tech/pages/topic-0/impact-of-age-on-disease-burden-and-vaccine-design.htmlDate
2024-04-27 00:00:00 UTCSite session
316Account
1Site
MS1Page
https://gsk-vaccines.infinityloop.tech/pages/topic-0/Burden_of_HZ_and_impact_on_patients/burden-of-hz-and-impact-on-patients.htmlDate
2024-04-27 05:45:47 UTCSite session
317Account
1Site
MS1Page
https://gsk-vaccines.infinityloop.tech/pages/topic-0/Burden_of_HZ_and_impact_on_patients/2.0.0.htmlDate
2024-04-27 05:45:47 UTCSite session
318Account
1Site
MS1Page
https://gsk-vaccines.infinityloop.tech/pages/home.htmlDate
2024-04-27 05:45:50 UTCSite session
317Account
1Site
MS1Page
https://gsk-vaccines.infinityloop.tech/index.htmlDate
2024-04-27 05:47:50 UTCSite session
317Account
1Site
MS3Page
https://gsk-ms3.infinityloop.tech/gsk-infectious-disease2.htmlDate
2024-04-27 05:47:59 UTCSite session
319Account
1Site
MS3Page
https://gsk-ms3.infinityloop.tech/pipeline-landing.htmlDate
2024-04-27 05:48:02 UTCSite session
319Account
1Site
MS3Page
https://gsk-ms3.infinityloop.tech/pipeline-diseases.htmlDate
2024-04-27 05:48:06 UTCSite session
319Account
1Site
MS3Page
https://gsk-ms3.infinityloop.tech/pipeline-infectious-diseases.htmlDate
2024-04-27 05:48:08 UTCSite session
319Account
1Site
MS3Page
https://gsk-ms3.infinityloop.tech/pipeline-infectious-diseases-2.htmlDate
2024-04-27 05:48:11 UTCSite session
319Account
1Site
MS3Page
https://gsk-ms3.infinityloop.tech/pipeline-infectious-diseases-3.htmlDate
2024-04-27 05:48:13 UTCSite session
319Account
1Site
MS3Page
https://gsk-ms3.infinityloop.tech/pipeline-none-infectious-diseases.htmlDate
2024-04-27 05:48:15 UTCSite session
319Account
1Site
MS3Page
https://gsk-ms3.infinityloop.tech/pipeline-none-infectious-diseases-2.htmlDate
2024-04-27 05:48:20 UTCSite session
319Account
1Site
MS3Page
https://gsk-ms3.infinityloop.tech/gsk-infectious-disease2.htmlDate
2024-04-27 05:48:22 UTCSite session
319Account
1Site
MS3Page
https://gsk-ms3.infinityloop.tech/gsk-landing-page.htmlDate
2024-04-27 05:48:24 UTCSite session
319Account
1Site
MS3Page
https://gsk-ms3.infinityloop.tech/gsk-desclamier.htmlDate
2024-04-27 05:48:26 UTCSite session
319Account
1Site
MS3Page
https://gsk-ms3.infinityloop.tech/gsk-emerging.htmlDate
2024-04-27 05:48:27 UTCSite session
319Account
1Site
MS3Page
https://gsk-ms3.infinityloop.tech/gsk-commitment.htmlDate
2024-04-27 05:48:28 UTCSite session
319Account
1Site
MS3Page
https://gsk-ms3.infinityloop.tech/gsk-landing-page.htmlDate
2024-04-27 05:48:29 UTCSite session
319Account
1Site
MS3Page
https://gsk-ms3.infinityloop.tech/gsk-infectious-disease2.htmlDate
2024-04-27 05:48:34 UTCSite session
319Account
1Create your first Page View
New Page View